Germany has approved the EU’s first Compassionate Use Program for psilocybin-assisted therapy in patients with treatment-resistant depression.
Press release: https://lnkd.in/dszzxE8a
Informationen: https://lnkd.in/ev4AG4Fy
@mind-foundation.bsky.social
MIND is a nonprofit mental health organization dedicated to research and education. We bring psychedelic therapy into public health care. https://mind-foundation.org x.com/mind_europe linkedin.com/company/mind-foundation-eu instagram.com/mind_europe
Germany has approved the EU’s first Compassionate Use Program for psilocybin-assisted therapy in patients with treatment-resistant depression.
Press release: https://lnkd.in/dszzxE8a
Informationen: https://lnkd.in/ev4AG4Fy
Acceptance of Psilocybin-Assisted Therapy in German-Speaking Countries
New @mind-foundation.bsky.social paper (in German): link.springer.com/article/10.1...
Important result: Informing people about potential benefits only increases acceptance when information on risks is also provided.
Today 6PM UTC+2: Psychologist and psychotherapist, leader of @mind-foundation.bsky.social's Augmented Psychotherapy Training program Max Wolff @trpwolff.bsky.social will present a free webinar about the qualities and competencies that psychedelic therapists should have and develop. Links in comment!
09.12.2024 14:59 — 👍 6 🔁 3 💬 1 📌 0Had a crowded INSIGHT Forum (right picture) on Wednesday - hosting David Nutt - with almost the full new APT course participating (after 10 hours of training ;-)).
22.11.2024 19:34 — 👍 1 🔁 0 💬 0 📌 0INSIGHT Conference 2023, MIND Foundation, Auditorium of the Langenbeck-Virchow-House, Charité, Berlin, Germany
INSIGHT Forum of the MIND Foundation, Nov 20, 2024, with Prof. Dr. David Nutt, Boxhagener Str. 78, 10243 Berlin
Welcome everyone. So far, the sky is much bluer over here - we'll stay on X for now and explore how this platform will fly. Happy to have a space that is not dominated by polarizing right-wing bots.
#webringpsychedelictherapyintopublichealthcare ;-)